NCT05658588View on ClinicalTrials.gov

Hemodynamic Impact of Cytosorb and CKRT in Children With Septic Shock

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

October 1, 2021

Study Completion Date

October 1, 2021

Conditions
Septic Shock
Interventions
DEVICE

Cytosorb

Cytosorb cartridge It is composed of polystyrene divinylbenzene and polyvinylpyrrolidone copolymers and targets molecules in the 5-50 kDa range, which includes the molecular mass of several cytokines

Trial Locations (1)

00151

Gabriella Bottari, Rome

All Listed Sponsors
lead

Ospedale Pediatrico Bambin Gesù

OTHER

NCT05658588 - Hemodynamic Impact of Cytosorb and CKRT in Children With Septic Shock | Biotech Hunter | Biotech Hunter